Speechvive Completes Funding To Move Speech Aid For Parkinson’s Patients To The Public

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAFAYETTE, Ind. & FORT WAYNE, Ind.--(BUSINESS WIRE)--SpeechVive Inc. announces the completion of nearly $700,000 in funding to move a speech aid innovation for people with Parkinson's disease to the public.

Ambassador Enterprises, an Indiana-based for-profit philanthropic equity investment firm, is providing Series A funding to support the U.S. sales launch of the SpeechVive device. The technology is a behind-the-ear smart device that helps people with Parkinson's disease speak more loudly and communicate more effectively.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC